RI
AXDX

RTW Investments’s Accelerate Diagnostics AXDX Stock Holding History

RTW Investments’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-7,484
Closed -$1.08M – 37
2016
Q2 		$1.08M Sell
7,484
-4,234
-36% -$568K 0.37% 27
2016
Q1 		$1.68M Buy
11,718
+971
+9% +$137K 0.61% 23
2015
Q4 		$2.31M Buy
+10,747
New +$1.96M 0.75% 20

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RTW Investments's AXDX Position: Q3 2016 in Review

RTW Investments sold out of Accelerate Diagnostics (AXDX) in Q3 2016, closing a stake of 7,484 shares — an estimated $1.08M sold.

RTW Investments first reported a position in AXDX in Q4 2015 and held it in 3 quarters. The position peaked at $2.31M in Q4 2015. 103 funds tracked by Wall St. Rank hold AXDX as of Q3 2016.

  • RTW Investments reported no remaining Accelerate Diagnostics position as of Q3 2016 after selling out during the quarter.
  • RTW Investments sold 7,484 Accelerate Diagnostics shares in Q3 2016, an estimated $1.08M.
  • RTW Investments first reported a position in Accelerate Diagnostics in Q4 2015 and held it in 3 quarters.
  • RTW Investments's Accelerate Diagnostics position peaked at $2.31M in Q4 2015.
  • 103 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2016.

Based on RTW Investments's 13F filing for Q3 2016, filed 14 Nov 2016.